Literature DB >> 20002307

Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin.

G Uddin1, D Shoeb, S Solaiman, R Marley, C Gore, M Ramsay, R Harris, I Ushiro-Lumb, S Moreea, S Alam, H C Thomas, S Khan, B Watt, R N Pugh, S Ramaiah, R Jervis, A Hughes, S Singhal, S Cameron, W F Carman, G R Foster.   

Abstract

The prevalence of hepatitis B and hepatitis C in immigrant communities is unknown. Immigrants from south Asia are common in England and elsewhere, and the burden of viral hepatitis in these communities is unknown. We aimed to determine the prevalence of viral hepatitis in immigrants from south Asia living in England, and we therefore undertook a community-based testing project in such people at five sites in England. A total of 4998 people attending community centres were screened for viral hepatitis using oral fluid testing. The overall prevalence of anti-hepatitis C virus (HCV) in people of south Asian origin was 1.6% but varied by country of birth being 0.4%, 0.2%, 0.6% and 2.7% in people of this ethnic group born in the UK, India, Bangladesh and Pakistan, respectively. The prevalence of hepatitis B surface antigen was 1.2%-0.2%, 0.1%, 1.5% and 1.8% in people of this ethnic group born in the UK, India, Bangladesh and Pakistan, respectively. Analysis of risk factors for HCV infection shows that people from the Pakistani Punjab and those who have immigrated recently are at increased risk of infection. Our study suggests that migrants from Pakistan are at highest risk of viral hepatitis, with those from India at low risk. As prevalence varies both by country and region of origin and over time, the prevalence in migrant communities living in western countries cannot be easily predicted from studies in the country of origin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20002307     DOI: 10.1111/j.1365-2893.2009.01240.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  26 in total

Review 1.  Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence.

Authors:  Daniele Mipatrini; Paola Stefanelli; Santino Severoni; Giovanni Rezza
Journal:  Pathog Glob Health       Date:  2017-02-06       Impact factor: 2.894

2.  The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study.

Authors:  Adam Trickey; Hannah Fraser; Aaron G Lim; Amy Peacock; Samantha Colledge; Josephine G Walker; Janni Leung; Jason Grebely; Sarah Larney; Natasha K Martin; Matthew Hickman; Louisa Degenhardt; Margaret T May; Peter Vickerman
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-04-10

Review 3.  Hepatitis B virus: where do we stand and what is the next step for eradication?

Authors:  Haruki Komatsu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

4.  Viral hepatitis prevalence in patients with active and latent tuberculosis.

Authors:  Hesam Ahmadi Nooredinvand; David W Connell; Mahmoud Asgheddi; Mohammed Abdullah; Marie O'Donoghue; Louise Campbell; Melissa I Wickremasinghe; Ajit Lalvani; Onn Min Kon; Shahid A Khan
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

Review 5.  Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.

Authors:  Masao Omata; Tatsuo Kanda; Osamu Yokosuka; Darrell Crawford; Mamun Al-Mahtab; Lai Wei; Alaaeldin Ibrahim; George K K Lau; Barjesh C Sharma; Saeed S Hamid; Wan-Long Chuang; A Kadir Dokmeci
Journal:  Hepatol Int       Date:  2015-05-05       Impact factor: 9.029

6.  Association of Patients' Geographic Origins with Viral Hepatitis Co-infection Patterns, Spain.

Authors:  Santiago Pérez Cachafeiro; Ana María Caro-Murillo; Juan Berenguer; Ferran Segura; Felix Gutierrez; Francesc Vidal; Maria Angeles Martinez-Perez; Julio Sola; Roberto Muga; Santiago Moreno
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

7.  Screening for chronic hepatitis B and C in migrants from Afghanistan, Iran, Iraq, the former Soviet Republics, and Vietnam in the Arnhem region, The Netherlands.

Authors:  C Richter; G Ter Beest; E H Gisolf; P VAN Bentum; C Waegemaekers; C Swanink; E Roovers
Journal:  Epidemiol Infect       Date:  2014-01-07       Impact factor: 4.434

8.  Global distribution and prevalence of hepatitis C virus genotypes.

Authors:  Jane P Messina; Isla Humphreys; Abraham Flaxman; Anthony Brown; Graham S Cooke; Oliver G Pybus; Eleanor Barnes
Journal:  Hepatology       Date:  2014-07-28       Impact factor: 17.425

9.  Hepatitis C Virus Core Mutations Associated with False-Negative Serological Results for Genotype 3a Core Antigen.

Authors:  Linh Thuy Nguyen; Linda Dunford; Ines Freitas; Paul Holder; Lan Anh Nguyen; Joanne O'Gorman; Jeff Connell; Michael Carr; William Hall; Cillian De Gascun
Journal:  J Clin Microbiol       Date:  2015-05-20       Impact factor: 5.948

10.  Low hepatitis B testing among migrants: a cross-sectional study in a UK city.

Authors:  Iro Evlampidou; Matthew Hickman; Charles Irish; Nick Young; Isabel Oliver; Sophie Gillett; Alexandra Cochrane
Journal:  Br J Gen Pract       Date:  2016-03-29       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.